Get the Stockscreener App
30.00
2.08%
0.61
After Hours:
30.00
Collegium Pharmaceutical Inc stock is traded at $30.00, with a volume of 216.38K.
It is up +2.08% in the last 24 hours and up +3.27% over the past month.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
See More
Previous Close:
$29.39
Open:
$29.19
24h Volume:
216.38K
Relative Volume:
0.58
Market Cap:
$944.35M
Revenue:
$566.77M
Net Income/Loss:
$48.16M
P/E Ratio:
25.21
EPS:
1.19
Net Cash Flow:
$274.29M
1W Performance:
+0.13%
1M Performance:
+3.27%
6M Performance:
-23.49%
1Y Performance:
-21.87%
1-Day Range:
$29.12
$30.02
1-Week Range:
$29.00
$30.52
52-Week Range:
$27.27
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Name
Collegium Pharmaceutical Inc
Sector
Phone
781-713-3699
Address
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
30.00 | 944.35M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Needham | Hold → Buy |
| Jul-30-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-07-24 | Upgrade | Jefferies | Hold → Buy |
| May-10-24 | Downgrade | Needham | Buy → Hold |
| May-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-04-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-25-23 | Reiterated | Needham | Buy |
| May-02-23 | Resumed | Jefferies | Buy |
| Aug-08-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-15-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Aug-06-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Jul-14-20 | Initiated | BWS Financial | Sell |
| May-27-20 | Initiated | Guggenheim | Neutral |
| Feb-19-20 | Resumed | Jefferies | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| May-03-19 | Resumed | H.C. Wainwright | Buy |
| Apr-12-19 | Resumed | Janney | Buy |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Jan-16-19 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-18 | Reiterated | Needham | Buy |
| Dec-05-17 | Reiterated | Needham | Buy |
| Sep-11-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Reiterated | Needham | Buy |
| Sep-13-16 | Initiated | Gabelli & Co | Buy |
| Jun-01-15 | Initiated | Jefferies | Buy |
| Jun-01-15 | Initiated | Needham | Buy |
| Jun-01-15 | Initiated | Piper Jaffray | Overweight |
View All
Collegium Pharmaceutical Inc Stock (COLL) Latest News
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - Barchart.com
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 - Investing.com India
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical - Benzinga
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Collegium Pharmaceutical chairman of the board to retire - MSN
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - The Globe and Mail
Amundi Has $446,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock By Investing.com - Investing.com Australia
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning - TipRanks
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock - Investing.com India
Collegium pharmaceutical CFO sells $29,313 in stock - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives By Investing.com - Investing.com Australia
Collegium Pharmaceutical announces board changes and new EVP By Investing.com - Investing.com Canada
Collegium announces updates to its board of directors, executive team - TipRanks
Collegium Announces Updates to its Board of Directors and Executive Leadership Team - citybiz
Collegium Pharmaceutical announces board changes and new EVP - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives - Investing.com India
Collegium Pharmaceutical Appoints New Executive VP and General Counsel - TipRanks
Collegium Announces Updates To Its Board Of Directors And Executive Leadership Team - Marketscreener.com
Collegium's Founder Steps Down as Company Unveils Strategic Leadership Overhaul - StockTitan
Bank of New York Mellon Corp Has $7.24 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium pharmaceutical CFO sells shares worth $313,412 By Investing.com - Investing.com Australia
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO sells shares worth $313,412 - Investing.com India
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 - Investing.com India
Have Collegium Pharmaceutical Insiders Been Selling Stock? - Simply Wall St
Collegium pharmaceutical EVP sells shares worth $169,299 By Investing.com - Investing.com South Africa
Collegium pharmaceutical CFO sells shares worth $103,591 - Investing.com India
Collegium pharmaceutical CFO sells shares worth $103,591 By Investing.com - Investing.com Canada
Collegium Announces Poster Presentations at the 2025 - GlobeNewswire
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care - GlobeNewswire Inc.
Collegium Pharmaceutical Executives Sell Shares - TradingView
Collegium pharmaceutical EVP sells shares worth $169,299 - Investing.com
Collegium Pharmaceutical Inc Stock (COLL) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.06%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):